Therapeutic Asset Ratings

204 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Vesanoid Non Small Cell Lung Cancer	Peking University People's Hospital	P3	B (56)
Etrumadenant Non Small Cell Lung Cancer	Gilead Sciences	P2	CCC (55)
Lurbinectedin Non Small Cell Lung Cancer	Fox Chase Cancer Center	P2	CCC (55)
rc48 Non Small Cell Lung Cancer	Sun Yat-sen University	P2	CCC (55)
Erythromycin Non Small Cell Lung Cancer	Qianfoshan Hospital	P3	CCC (54)
Ociperlimab Non Small Cell Lung Cancer	Novartis Pharmaceuticals	P3	CCC (54)
Sugemalimab Non Small Cell Lung Cancer	CStone Pharmaceuticals	P3	CCC (54)
Zirconium Zr 89 Crefmirlimab Berdoxam Non Small Cell Lung Cancer	Memorial Sloan Kettering Cancer Center	P2	CCC (54)
Uliledlimab Non Small Cell Lung Cancer	TJ Biopharma Co., Ltd.	P2/3	CCC (54)
Durvalumab Non Small Cell Lung Cancer	ETOP IBCSG Partners Foundation	P3	CCC (52)
JYP0322 Non Small Cell Lung Cancer	Guangzhou JOYO Pharma Co., Ltd	P3	CCC (52)
Lorazepam Non Small Cell Lung Cancer	Merck Sharp & Dohme LLC	P3	CCC (52)
UMECLIDINIUM Non Small Cell Lung Cancer	Samsung Medical Center	P3	CCC (52)
VILANTEROL Non Small Cell Lung Cancer	Samsung Medical Center	P3	CCC (52)
Alpelisib Non Small Cell Lung Cancer	Wen-zhao ZHONG	P2	CCC (52)
Arimidex Non Small Cell Lung Cancer	Eli Lilly and Company	P2	CCC (52)
Bgb-A445 Non Small Cell Lung Cancer	BeiGene	P2	CCC (52)
gt103 Non Small Cell Lung Cancer	Jeffrey Clarke	P2	CCC (52)
Guadecitabine Non Small Cell Lung Cancer	Italian Network for Tumor Biotherapy Foundation	P2	CCC (52)
hlx43 Non Small Cell Lung Cancer	Shanghai Henlius Biotech	P2	CCC (52)
Pembrolizumab Non Small Cell Lung Cancer	Amsterdam UMC, location VUmc	P2	CCC (52)
(-)-SIRPIGLENASTAT Non Small Cell Lung Cancer	NYU Langone Health	P2	CCC (52)
vs-7375 Non Small Cell Lung Cancer	Verastem, Inc.	P2	CCC (52)
Glyceryl Trinitrate Non Small Cell Lung Cancer	Instituto Nacional de Cancerologia de Mexico	P2	CCC (51)
Immunoglobulin G1 [300-alanine], anti-(human CD73 antigen) (human-Mus musculus monoclonal TJ004309 ?1-chain), disulfide with human-Mus musculus monoclonal TJ004309 ?-chain, dimer Non Small Cell Lung Cancer	I-Mab Biopharma US Limited	P2	CCC (51)

Showing 51 to 75 of 204 assets

PreviousPage 3 of 9Next